ONC
BeOne Medicines Ltd
81 hedge funds and large institutions have $2.61B invested in BeOne Medicines Ltd in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
42% more funds holding
Funds holding: 57 → 81 (+24)
0.91% more ownership
Funds ownership: 3.93% → 4.84% (+0.91%)
Holders
81
Holding in Top 10
9
Calls
$7.15M
Puts
$2.41M
Top Buyers
| 1 | +$134M | |
| 2 | +$62.1M | |
| 3 | +$51.7M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$34.7M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$33.7M |
Top Sellers
| 1 | -$18.1M | |
| 2 | -$15.3M | |
| 3 | -$15.3M | |
| 4 |
ACM
Ariose Capital Management
Central, Hong Kong,
Hong Kong
|
-$14.6M |
| 5 |
UONDDL
University of Notre Dame du Lac
South Bend,
Indiana
|
-$3.09M |